Join Growin Stock Community!

Wellgistics health, inc.WGRX.US Overview

US StockConsumer Defensive
(No presentation for WGRX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

WGRX AI Insights

WGRX Overall Performance

WGRX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

WGRX Recent Performance

-2.76%

Wellgistics health, inc.

-1.34%

Avg of Sector

-0.31%

S&P500

WGRX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

WGRX Key Information

WGRX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

WGRX Profile

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Price of WGRX

WGRX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

WGRX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.11
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.72
PB Ratio
3.61
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
7.86%
Net Margin
-228.17%
Revenue Growth (YoY)
-15.00%
Profit Growth (YoY)
-18.64%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.11
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.72
PB Ratio
3.61
Price-to-FCF
-
Gross Margin
7.86%
Net Margin
-228.17%
Revenue Growth (YoY)
-15.00%
Profit Growth (YoY)
-18.64%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
  • When is WGRX's latest earnings report released?

    The most recent financial report for Wellgistics health, inc. (WGRX) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating WGRX's short-term business performance and financial health. For the latest updates on WGRX's earnings releases, visit this page regularly.

  • What is the operating profit of WGRX?

    According to the latest financial report, Wellgistics health, inc. (WGRX) reported an Operating Profit of -31.55M with an Operating Margin of -1,047.11% this period, representing a decline of 1,723.83% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is WGRX's revenue growth?

    In the latest financial report, Wellgistics health, inc. (WGRX) announced revenue of 3.01M, with a Year-Over-Year growth rate of 124.52%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does WGRX have?

    As of the end of the reporting period, Wellgistics health, inc. (WGRX) had total debt of 29.99M, with a debt ratio of 0.57. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does WGRX have?

    At the end of the period, Wellgistics health, inc. (WGRX) held Total Cash and Cash Equivalents of 4.38M, accounting for 0.08 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does WGRX go with three margins increasing?

    In the latest report, Wellgistics health, inc. (WGRX) did not achieve the “three margins increasing” benchmark, with a gross margin of 7.7%%, operating margin of -1,047.11%%, and net margin of -1,139%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess WGRX's profit trajectory and future growth potential.

  • Is WGRX's EPS continuing to grow?

    According to the past four quarterly reports, Wellgistics health, inc. (WGRX)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.46. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of WGRX?

    Wellgistics health, inc. (WGRX)'s Free Cash Flow (FCF) for the period is -1.36M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 173.94% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of WGRX?

    The latest valuation data shows Wellgistics health, inc. (WGRX) has a Price-To-Earnings (PE) ratio of -0.67 and a Price/Earnings-To-Growth (PEG) ratio of -0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.